BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21272617)

  • 1. Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease.
    Anzilotti S; Giampà C; Laurenti D; Perrone L; Bernardi G; Melone MA; Fusco FR
    Brain Res Bull; 2012 Feb; 87(2-3):350-8. PubMed ID: 21272617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.
    Kim J; Waldvogel HJ; Faull RL; Curtis MA; Nicholson LF
    J Neurochem; 2015 Sep; 134(5):927-42. PubMed ID: 26011179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
    Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
    Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of neuroglobin in the brain of R6/2 mouse model of Huntington's disease.
    Cardinale A; Fusco FR; Paldino E; Giampà C; Marino M; Nuzzo MT; D'Angelo V; Laurenti D; Straccia G; Fasano D; Sarnataro D; Squillaro T; Paladino S; Melone MAB
    Neurol Sci; 2018 Feb; 39(2):275-285. PubMed ID: 29101592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
    Farrar AM; Callahan JW; Abercrombie ED
    Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice.
    Kosinski CM; Cha JH; Young AB; Mangiarini L; Bates G; Schiefer J; Schwarz M
    Neuroreport; 1999 Dec; 10(18):3891-6. PubMed ID: 10716229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.
    Rajput PS; Kharmate G; Norman M; Liu SH; Sastry BR; Brunicardi CF; Kumar U
    PLoS One; 2011; 6(9):e24467. PubMed ID: 21912697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic neuronal defect without cell loss in Huntington's disease.
    Smith R; Chung H; Rundquist S; Maat-Schieman ML; Colgan L; Englund E; Liu YJ; Roos RA; Faull RL; Brundin P; Li JY
    Hum Mol Genet; 2006 Nov; 15(21):3119-31. PubMed ID: 16987871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.
    Bissonnette S; Vaillancourt M; Hébert SS; Drolet G; Samadi P
    PLoS One; 2013; 8(9):e75099. PubMed ID: 24040390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
    Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
    Ma L; Nicholson LF
    Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease.
    Okita S; Morigaki R; Koizumi H; Kaji R; Nagahiro S; Goto S
    Neuroscience; 2012 Jan; 202():363-70. PubMed ID: 22155493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for Advanced Glycation End Products (RAGE) is Expressed Predominantly in Medium Spiny Neurons of tgHD Rat Striatum.
    Shi D; Chang JW; Choi J; Connor B; O'Carroll SJ; Nicholson LFB; Kim JH
    Neuroscience; 2018 Jun; 380():146-151. PubMed ID: 29625216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
    García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
    J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
    Crocker SF; Costain WJ; Robertson HA
    Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.